Psychedelics’ dark side: New model reveals risks of false insights and beliefs

Researchers introduce the FIBUS model to explain how psychedelics can lead to false insights and beliefs, highlighting the need for careful clinical evaluation to optimize therapeutic outcomes.

Pfizer gets an FDA win in hemophilia after a rough week

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 13, 2024

PSMA PET Beats MRI in Prostate Cancer Staging Study

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II

July 3, 2024

Opinion | Life as an Olympic Doctor

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is

August 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.